NCT04076215

Brief Summary

Post-traumatic stress disorder (PTSD) is characterized by physiological changes, some of which are thought to be chronic, while others are observed in response to stressogenic stimuli. A psychiatric diagnosis of PTSD is currently based mainly on non-quantitative elements, such as interviews and subjective impressions. Discernable patterns of stress-related measures may constitute a physiological and biochemical phenotype characteristic of PTSD, which may serve as a biomarker and support diagnostic decisions, as well as personalized treatment plans. The current study is aimed at examining the possibility of basing a psychiatric diagnosis by measuring changes in the biochemical phenotype of participants with PTSD. Physiological and biochemical data will be collected from participants with and without PTSD using wearable sensors and adhesive biosensor patches. The data will be collected in two conditions: in a neutral, quiet situation, and during and following exposure to controlled stressogenic stimuli.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2019

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 22, 2019

Completed
10 days until next milestone

Study Start

First participant enrolled

September 1, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 3, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2020

Completed
Last Updated

September 3, 2019

Status Verified

August 1, 2019

Enrollment Period

5 months

First QC Date

August 22, 2019

Last Update Submit

August 29, 2019

Conditions

Outcome Measures

Primary Outcomes (24)

  • Significant differences between groups - HRV

    Significant differences in Heart Rate Variability - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in physiological changes between groups - temperature

    Significant differences in physiological changes - body temperature- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in physiological changes between groups - SPO2

    Significant differences in physiological changes - Saturation SPO2- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in physiological changes between groups - blood pressure

    Significant differences in physiological changes - continuous blood pressure- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in physiological changes between groups - pulse pressure

    Significant differences in physiological changes - pulse pressure - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in physiological changes between groups -respiratory rate

    Significant differences in physiological changes - respiratory rate- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in physiological changes between groups -stroke volume

    Significant differences in physiological changes - stroke volume- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in physiological changes between groups -cardiac output

    Significant differences in physiological changes - cardiac output - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in physiological changes between groups - systemic vascular resistance

    Significant differences in physiological changes - systemic vascular resistance- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in cortisol levels between groups

    Significant differences in biochemical changes - cortisol - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in biochemical changes between groups - C-reactive protein

    Significant differences in biochemical changes - C-reactive protein - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in biochemical changes between groups - Interleukin 6

    Significant differences in biochemical changes - Interleukin 6 - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in biochemical changes between groups - N-terminal B-type natriuretic peptide

    Significant differences in biochemical changes - N-terminal B-type natriuretic peptide - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in biochemical changes between groups - 8-oxo-7

    Significant differences in biochemical changes - 8-oxo-7- between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in biochemical changes between groups - 8-dihydro-2'-deoxyguanosine

    Significant differences in biochemical changes - 8-dihydro-2'-deoxyguanosine - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in biochemical changes between groups - hexanone

    Significant differences in biochemical changes - hexanone - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in biochemical changes between groups - acetic acid

    Significant differences in biochemical changes - acetic acid - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in biochemical changes between groups - heptane

    Significant differences in biochemical changes - heptane - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in biochemical changes between groups - hexanal

    Significant differences in biochemical changes -hexanal - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in biochemical changes between groups - 3-heptanone

    Significant differences in biochemical changes - 3-heptanone - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in biochemical changes between groups - hexanoic acid

    Significant differences in biochemical changes - hexanoic acid - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in biochemical changes between groups - heptanal

    Significant differences in biochemical changes -heptanal - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in biochemical changes between groups - nonanal

    Significant differences in biochemical changes - nonanal - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

  • Significant differences in biochemical changes between groups - glucose

    Significant differences in biochemical changes - glucose - between groups (participants with PTSD and controls) before and after exposure to stressogenic stimuli

    3 hours

Study Arms (2)

Pariticapnts with PTSD

EXPERIMENTAL
Behavioral: Stressogenic stimulusDevice: Biobeat smart watch and adhesive biosensor patches.

Pariticapnts without PTSD (controls)

EXPERIMENTAL
Behavioral: Stressogenic stimulusDevice: Biobeat smart watch and adhesive biosensor patches.

Interventions

Participants will be exposed to an anxiety-provoking stimulus for 15-20 minutes, in a controlled setting

Pariticapnts with PTSDPariticapnts without PTSD (controls)

Physiological and biochemical measures will be obtained using the Biobeat smart watch and adhesive biosensor patches.

Pariticapnts with PTSDPariticapnts without PTSD (controls)

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • PTSD diagnosis (excluding controls)
  • Proper ability to give informed consent

You may not qualify if:

  • Active oncological/cardiovascular condition
  • Dialysis patients
  • Active psychotic or suicidal symptoms
  • Severe dissociative symptoms
  • A traumatic brain injury (TBI) diagnosis
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

August 22, 2019

First Posted

September 3, 2019

Study Start

September 1, 2019

Primary Completion

February 1, 2020

Study Completion

June 1, 2020

Last Updated

September 3, 2019

Record last verified: 2019-08